Relationships between fasting plasma insulin, anthropometrics, and metabolic parameters in a very old healthy population

Metabolism: Clinical and Experimental

Volumn 47, Issue 5, 1998, Pages 535-540

  Carantoni, M ^b   Zuliani, G ^b   Volpato, S ^b   Palmieri, E ^b   Mezzetti, A ^b   Vergnani, L ^b   Fellin, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; PLASMINOGEN ACTIVATOR INHIBITOR 1;

AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; SYNDROME X;

EID: 0031943394     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90236-0     Document Type: Article

References (39)

1. Wenger NK, O'Rourke RA, Marcus FI: The care of elderly patients with cardiovascular disease. Ann Intern Med 109:425-428, 1989
2. Kapantais G, Powell-Griner E: Characteristics of persons dying of diseases of heart. Preliminary data from the 1986 National Mortality Followback Survey Advance Data. Vital Health Stat 17:1-32, 1989
3. Karvonen MJ: Determinants of cardiovascular diseases in the elderly. Ann Med 21:3-12, 1989
4. Modan M, Halkin H, Almog S, et al: Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance. J Clin Invest 75:805-817, 1985
5. Laasko M, Sarlund H, Mykkanen L: Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223-231, 1990
6. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
7. Reaven GM: Syndrome X: 6 years later. J Intern Med 23:13-22, 1994
8. Andersen P: Hypercoagulability and reduced fibrinolysis in hyperlipidemia: Relationship to metabolic cardiovascular syndrome. J Cardiovasc Pharmacol 20:s29-s31, 1992 (suppl)
9. Feskens EJM, Kromhout D: Hyperinsulinemia, risk factors and coronary heart disease: The Zuphten Elderly Study. Arterioscler Thromb 14:1641-1647, 1994
10. Mykkanen L, Knusisto J, Haffner SM, et al: Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thomb 14:518-526, 1994
11. den Toukelaar ID, Seidell JC, Van Noord PAH, et al: Fat distribution in relation to age, degree of obesity, smoking habits, parity and estrogen use: A cross-sectional study in 11,825 Dutch women participating in the DOM-project. Int J Obes 14:753-761, 1990
12. Stevens J, Knapp RG, Keil JE, et al: Changes in body weight and girths in black and white adults studied over a 25 year interval. Int J Obes 15:803-808, 1991
13. Cefalu WT, Wang ZA, Werbel S, et ai: Contribution of visceral fat mass to the insulin resistance of aging. Metabolism 44:954-959, 1995
14. Bjorntorp P: Adipose tissue distribution and morbidity, in Berry EM, Blondhnin SH, Eliahou HE, et al (eds): Recent Advances in Obesity. London, England, Libbey, 1987, pp 60-65
15. Smith SR, Chhetri MK, Johanson AJ, et al: The pituitary-gonadal axis in men with protein-calorie malnutrition. J Clin Endocrinol Metab 41:60-64, 1975
16. Brodows RG: Starvation enhances the ability of insulin to inhibit its own secretion. Metabolism 34:53-57, 1985
17. Zuliani G, Bader G, Imbastaro T, et al: Lipoprotein (a) plasma levels and apo (a) isoforms are not associated with longevity or disability in a sample of Italian octo-nonagenarians. Aging Clin Exp Res 7:385-391, 1995
18. Mezzetti A, Lapenna D, Costantini F, et al: Systemic oxidative stress and its relationship with aging. A cross sectional study. J Am Geriatr Soc 44:1-5, 1996
19. Katz S, Downs TD, Cash HR, et al: Progress in the development of the index of ADL. Gerontologist 1:20-30, 1970
20. Rose GA, Blackburn H, Gillum RF, et al: Cardiovascular Survey Methods. Geneva, Switzerland, World Health Organization, 1982, pp 162-165
21. Allain CC, Poom LS, Chang CSG, et al: Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475, 1974
22. Walhefeld AW: Triglycerides determination after enzymatic hydrolysis, in Bergmeyer UU (ed): Methods of Enzymatic Analysis. Weinheim, Germany, Verlag Chemie, 1974, pp 1831-1835
23. Gidez LE, Miller GJ, Burstein M, et al: Separation and quantitation of subclasses of human plasma high-density lipoprotein by a simple precipitation procedure. J Lipid Res 23:1206-1223, 1982
24. Friedewald WT, Levy RI, Fredrikson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
25. Stief TW, Lenz P, Becker U, et al: Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in presence of oxidants: A novel principle. Thromb Res 50:559-573, 1988
26. Nilsson IM, Ljungner H, Tengborn L: Two different mechanisms in patients with venous thrombosis and defective fibrinolysis; low concentrations of plasminogen activator inhibitor. Br Med J 290:1453-1456, 1985
27. Zavaroni I, Bonora E, Pagliara M, et al: Risk factors for coronary disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706, 1989
28. Laasko M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
29. Blunt BA, Barrett-Connor E, Wingard DL: Evaluation of fasting plasma glucose as screening test for NIDDM in older adults - Rancho Bernardo Study - Diabetes Care 14:989-993, 1991
30. Haffner SM, Valdez RA, Hazuda HP, et al: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722, 1992
31. Alessi MC, Juhan-Vague I, Kooistra T, et al: Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line HepG2. Thromb Haemost 60:491-494, 1988
32. Mehta J, Mehta P, Lawson D, et al: Plasma plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglycerides concentrations. J Am Coll Cardiol 9:263-267, 1987
33. Hashimoto Y, Kobayashi A, Yamazaki N, et al: Relationship between age and plasma t-PA, PA-inhibitor and PA activity. Thromb Res 46:625-629, 1987
34. Cigolini M, Seidell JC, Charzewska J, et al: Fasting serum insulin in relation to fat distribution, serum lipid profile, and blood pressure in European women: The European Fat Distribution Study. Metabolism 40:781-787, 1991
35. Strandeberg TE, Tilvis RS, Lindberg, et al: High plasma insulin associates with lower LDL-cholesterol in elderly individuals. Atherosclerosis 121:267-273, 1996
36. Ducimentiere P, Eschwege E, Papoz L, et al: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease in a middle-aged population. Diabetologia 19:205-210, 1980
37. Despres JP, Lamarche B, Mauriege P, et al: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
38. Welin L, Eriksson H, Larsson B, et al: Hyperinsulinemia is not a major coronary risk factor in elderly men: The Study of Men Born in 1913. Diabetologia 35:766-770, 1992
39. Wang PW, Abbasi F, Carantoni M, et al: Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers. J Clin Endocrinol Metab 82:3221-3224, 1997